Chief Scientific and Development Officer · Opus Genetics, Inc. (IRD)

Ashwath Jayagopal

A named executive officer of Opus Genetics in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$764,848

FY2024: $1,242,154

Compensation figures as of the proxy filed March 23, 2026 (DEF 14A).

Ashwath Jayagopal compensation by year

Opus Genetics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Opus Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$354,023$416,000
Bonus$50,000$50,000
Stock awards$199,500$48,825
Option awards$477,286$33,663
Non-equity incentive$151,345$205,920
Pension and deferred compensation$0$0
All other$10,000$10,440
Total$1,242,154$764,848

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed March 23, 2026, accession 0001140361-26-010757, and prior-year filings. Open the filing on EDGAR.

$1.2M
$765K
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Opus Genetics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
George MagrathChief Executive Officer$1,493,383
Ashwath Jayagopal · this pageChief Scientific and Development Officer$764,848
Joseph SchachleChief Operating Officer$718,408

The full Opus Genetics compensation record

free company brief

This page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Opus Genetics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy